Evoke Pharma Inc (EVOK)

5.5200 +0.5400 (+10.84%)
Closed USD Disclaimer
5.5200 0.0000 (0.0000%)

Evoke Pharma Inc Company Profile

Industry
Pharmaceuticals
Sector
Healthcare
Employees
4
Equity Type
ORD
Evoke Pharma, Inc. (Evoke) is a specialty pharmaceutical company that owns and operates in the development and commercialization of pharmaceutical products. The Company is focused primarily on the development and commercialization of drugs to treat gastrointestinal (GI) disorders and diseases. Evoke is developing its product Gimoti (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis. Gimoti, is a dopamine antagonist / mixed 5-HT3 antagonist / 5-HT4 agonist with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis. Gimoti is a formulation of metoclopramide offering systemic delivery by nasal spray administration.
Contact Information
Address
Solana Beach,92075 United States
Phone
858 345 1494
Fax
-
Top Executives
Name
Age
Since
Title
David A. Gonyer 57 2007 Co-Founder, CEO, President & Director
Cam L. Garner 73 2007 Independent Chairman of the Board
Malcolm R. Hill 64 2007 Independent Director
Todd C. Brady 50 2007 Independent Director
Kenneth J. Widder 69 2007 Independent Director
Vickie W. Reed 60 2021 Independent Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.